Pfizer raises 2026 outlook as cancer drug sales increase
Pfizer raised its 2026 outlook after cancer drugs and other medicines offset falling Covid sales, with patent expirations and pipeline results still ahead.
Pfizer raised its 2026 outlook after cancer drugs and other medicines offset falling Covid sales, with patent expirations and pipeline results still ahead.
OpenAI says former Army Secretary Dan Driscoll will advise on national security AI and work with U.S. allies in a newly created…
Apple's reported J595 home robot could combine FaceTime and lighting controls, with a possible $1,000 price and a 2027 launch that may…
Huawei reportedly asked some AI chip buyers to source HBM themselves. Supply-chain accounts and a broker’s $4,000 price estimate remain unverified.
Nvidia reportedly wants cloud partners to sell at least 51% of services to non-Chinese firms under rules for new contracts, leaving existing…
Anthropic says future models may soon meet its AI research acceleration threshold, while no existing model has been designated as exceeding the…
Ben Meer’s February 2023 reflection routine combines three personal goals with morning writing and evening journaling about love, experiences and learning.